相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?
Joao Pedro Ferreira et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial
Arnaud Olivier et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone
Phillip H. Lam et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Comparison of Propensity Score Methods and Covariate Adjustment Evaluation in 4 Cardiovascular Studies
Markus C. Elze et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Potassium lowering agents: Recommendations for physician and patient education, treatment reappraisal, and serial monitoring of potassium in patients with chronic hyperkalemia
Bertram Pitt et al.
PHARMACOLOGICAL RESEARCH (2017)
Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial
Michel Azizi et al.
CIRCULATION (2016)
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF
Adriaan A. Voors et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Barriers to Adoption of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure: A Mixed-Methods Study
Sandesh Dev et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice
Brian Bostick et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure
Lauren B. Cooper et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Bryan Williams et al.
LANCET (2015)
Temporal Trends and Hospital Variation in Mineralocorticoid Receptor Antagonist Use in Veterans Discharged With Heart Failure
Sandesh Dev et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy Results From the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)
Patrick Rossignol et al.
CIRCULATION-HEART FAILURE (2014)
Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist
Orly Vardeny et al.
CIRCULATION-HEART FAILURE (2014)
Incident hyperkalemia may be an independent therapeutic target in low ejection fraction heart failure patients: Insights from the HEAAL study
P. Rossignol et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: Lessons from randomized controlled trials and registries
Patrick Rossignol et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure
Lesley H. Curtis et al.
AMERICAN HEART JOURNAL (2013)
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Effectiveness of a multidimensional home nurse led heart failure disease management program-A French nationwide time-series comparison
Nelly Agrinier et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function Analyses of the EMPHASIS-HF Study Subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)
Romain Eschalier et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice
Faiez Zannad et al.
EUROPEAN HEART JOURNAL (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction
Adrian F. Hernandez et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Influence of Baseline and Worsening Renal Function on Efficacy of Spironolactone in Patients With Severe Heart Failure
Orly Vardeny et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Potential impact of optimal implementation of evidence-based heart failure therapies on mortality
Gregg C. Fonarow et al.
AMERICAN HEART JOURNAL (2011)
A trial-based economic evaluation of 2 nurse-led disease management programs in heart failure
Douwe Postmus et al.
AMERICAN HEART JOURNAL (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Adherence to Aldosterone-Blocking Agents in Patients with Heart Failure
Jay Margolis et al.
AMERICAN JOURNAL OF THERAPEUTICS (2010)
EURObservational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot)
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Heart Failure Guidelines, Performance Measures, and the Practice of Medicine Mind the Gap
Jalal K. Ghali et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Use of Aldosterone Antagonists in Heart Failure
Nancy M. Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008
Kenneth Dickstein et al.
EUROPEAN HEART JOURNAL (2008)
Cardiologists' awareness and perceptions of guidelines for chronic heart failure. The ADDress your Heart survey
Leif Erhardt et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Drug Insight: aldosterone-receptor antagonists in heart failure - the journey continues
Srinivasa R. Kalidindi et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2007)
Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers
Marsha A. Raebel et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Use and side-effect profile of spironolactone in a private cardiologist's practice
EM Williams et al.
CLINICAL CARDIOLOGY (2006)
The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure
KB Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001
FA Masoudi et al.
CIRCULATION (2005)
Rates of hyperkalemia after publication of the randomized aldactone evaluation study
DN Juurlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Complications of inappropriate use of spiroholactone in heart failure: When an old medicine spirals out of new guidelines
B Bozkurt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
The EPHESUS trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction
B Pitt et al.
CARDIOVASCULAR DRUGS AND THERAPY (2001)
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure - Insights from the Randomized Aldactone Evaluation Study (RALES)
F Zannad et al.
CIRCULATION (2000)
分享论文
